Neurochemical signs of astrocytic and neuronal injury in acute COVID‐19 normalizes during long‐term follow‐up
Nelly Kanberg(Sahlgrenska University Hospital), Magnus Gisslén(University of Gothenburg), Staffan Nilsson(Chalmers University of Technology), Kaj Blennow(Sahlgrenska University Hospital), Bengt Nellgård(Sahlgrenska University Hospital), Arvid Edén(Sahlgrenska University Hospital), Pär‐Daniel Sundvall(Region Västra Götaland), Henrik Zetterberg(National Hospital for Neurology and Neurosurgery), Nicholas J. Ashton(King's College London), Lars‐Magnus Andersson(University of Gothenburg), Joel Simrén(Sahlgrenska University Hospital)
Cited by 4
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k